Efficacy and safety of trimodulin, a novel polyclonal antibody preparation, in patients with severe community-acquired pneumonia : a randomized, placebo-controlled, double-blind, multicenter, phase II trial (CIGMA study)

DSpace Repository

Efficacy and safety of trimodulin, a novel polyclonal antibody preparation, in patients with severe community-acquired pneumonia : a randomized, placebo-controlled, double-blind, multicenter, phase II trial (CIGMA study)

Author: Welte, Tobias; Dellinger, R. Phillip; Ebelt, Henning; Ferrer, Miguel; Opal, Steven M.; Singer, Mervyn; Vincent, Jean-Louis; Werdan, Karl; Martin-Loeches, Ignacio; Almirall, Jordi; Artigas, Antonio; Ignacio Ayestaran, Jose; Nuding, Sebastian; Ferrer, Ricard; Sirgo Rodriguez, Gonzalo; Shankar-Hari, Manu; Alvarez-Lerma, Francisco; Riessen, Reimer; Sirvent, Josep-Maria; Kluge, Stefan; Zacharowski, Kai; Bonastre Mora, Juan; Lapp, Harald; Woebker, Gabriele; Achtzehn, Ute; Brealey, David; Kempa, Axel; Sanchez Garcia, Miguel; Brederlau, Joerg; Kochanek, Matthias; Reschreiter, Henrik Peer; Wise, Matthew P.; Belohradsky, Bernd H.; Bobenhausen, Iris; Dalken, Benjamin; Dubovy, Patrick; Langohr, Patrick; Mayer, Monika; Schuettrumpf, Joerg; Wartenberg-Demand, Andrea; Wippermann, Ulrike; Wolf, Daniele; Torres, Antoni
Tübinger Autor(en):
Riessen, Reimer
Published in: Intensive Care Medicine (2018), Bd. 44, H. 4, S. 438-448
Verlagsangabe: Springer
Language: English
Full text: http://dx.doi.org/10.1007/s00134-018-5143-7
ISSN: 1432-1238
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)